CBDX | Curative Biosciences, Inc. Annual & Quarterly

Annual Income Statements

(In USD)

Breakdown	2017	2016
Revenue	-	-
Cost of Revenue	2848.00	2848.00
Gross Profit	-2848.00	-2848.00
Operating Expenses	50.34 Thousand	1.63 Million
Selling, General and Administrative Expenses	50.34 Thousand	1.58 Million
Research and Development Expenses	-	50 Thousand
Other Expenses	-	-
Cost and Expenses	53.19 Thousand	1.64 Million
Operating Income	-53.2 Thousand	-1.64 Million
Interest Expense	-	-
Income Tax Expense	2.00	3.00
Earnings before Tax	-53.19 Thousand	-1.65 Million
Net Income	-53.19 Thousand	-1.65 Million
Earnings Per Share Basic	-0.00	-0.12
Earnings Per Share Diluted	-0.00	-0.12
Weighted Average Shares Outstanding	15.7 Million	13.92 Million
Weighted Average Shares Outstanding (Diluted)	15.7 Million	13.92 Million
Gross Margin	-	-
EBIT Margin	-	-
Profit Margin	-	-
EBITDA	-50.34 Thousand	-1.65 Million
Earnings Before Tax Margin	-	-

Breakdown	2016 FY	2015 FY
Revenue	-	-
Cost of Revenue	2848.00	2848.00
Gross Profit	-2848.00	-2848.00
Operating Expenses	50.34 Thousand	1.63 Million
Selling, General and Administrative Expenses	-	-
Research and Development Expenses	-	-
Other Expenses	-	-
Cost and Expenses	53.19 Thousand	1.64 Million
Operating Income	-53.2 Thousand	-1.64 Million
Interest Expense	-	-
Income Tax Expense	2.00	3.00
Earnings before Tax	-53.19 Thousand	-1.65 Million
Net Income	-53.19 Thousand	-1.65 Million
Earnings Per Share Basic	-	-
Earnings Per Share Diluted	-	-
Weighted Average Shares Outstanding	15.7 Million	13.92 Million
Weighted Average Shares Outstanding (Diluted)	15.7 Million	13.92 Million
Gross Margin	-	-
EBIT Margin	-	-
Profit Margin	-	-
EBITDA	-	-
Earnings Before Tax Margin	-	-